Genetically modified human placenta-derived mesenchymal stem cells with FGF-2 and PDGF-BB enhance neovascularization in a model of hindlimb ischemia

Ischemic diseases represent a challenging worldwide health burden. The current study investigated the therapeutic potential of genetically modified human placenta-derived mesenchymal stem cells (hPDMSCs) with basic fibroblast growth factor (FGF2) and platelet-derived growth factor-BB (PDGF-BB) genes...

Descripción completa

Detalles Bibliográficos
Autores principales: YIN, TAO, HE, SISI, SU, CHAO, CHEN, XIANCHENG, ZHANG, DONGMEI, WAN, YANG, YE, TINGHONG, SHEN, GUOBO, WANG, YONGSHENG, SHI, HUASHAN, YANG, LI, WEI, YUQUAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581748/
https://www.ncbi.nlm.nih.gov/pubmed/26239842
http://dx.doi.org/10.3892/mmr.2015.4089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581748/
https://www.ncbi.nlm.nih.gov/pubmed/26239842
http://dx.doi.org/10.3892/mmr.2015.4089

Ejemplares similares